Apr 18 |
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is largely controlled by institutional shareholders who own 65% of the company
|
Apr 13 |
Jim Cramer’s 10 Favorite Healthcare Stock Picks in 2024
|
Apr 6 |
Catalyst Pharmaceuticals: Revenue Growth Lagging Expense Growth (Rating Downgrade)
|
Mar 29 |
Why Is Catalyst (CPRX) Down 0.6% Since Last Earnings Report?
|
Mar 28 |
Catalyst Pharmaceuticals Announces Support for the Inaugural Lambert-Eaton Myasthenic Syndrome (LEMS) Awareness Day
|
Mar 27 |
Catalyst Pharmaceuticals to Participate in the 2024 Cantor Virtual Muscular Dystrophy Symposium
|
Mar 27 |
3 Strong Buy Biotech Stocks to Add to Your Q2 Must-Watch List
|
Mar 22 |
Investors in Catalyst Pharmaceuticals (NASDAQ:CPRX) have seen strong returns of 271% over the past three years
|
Mar 20 |
Crinetics Pharmaceuticals (CRNX) Stock Jumps 19.1%: Will It Continue to Soar?
|
Mar 19 |
7 Biotech Stocks Ready to Ride the Sector’s Resurgence
|